Since the 1970s, plants have been explored as alternatives to mammalian, insect, and bacterial cell cultures for the commercial production of recombinant proteins and protein therapeutics 1. Plant-based systems for the expression of biopharmaceuticals have shown promise in recent years as several novel treatments for diseases, like Gaucher's Disease 2, and avian H5N1 influenza 3, have shown success in clinical trials. The development of competent mechanisms for recombinant protein expression in plants in the decades since those initial experiments has created the potential for plant-based systems to alter the current paradigm of protein production for three primary reasons. Firstly, there is a notable decrease in cost as mammalian, insect, and bacterial bioreactors require considerable startup costs, expensive growth media, and complicated processes for downstream purification 4. The creation of stable transgenic plant lines also allows them to outpace the scalability of other expression systems as protein expressing plants could be grown and harvested on an agricultural scale 5. Secondly, plant-based expression systems significantly reduce the risk of transmitting a human or animal pathogen from the protein-expressing host to humans, demonstrating superiority in public safety 6. Lastly, plants utilize a eukaryotic endomembrane system that is similar to mammalian cells, allowing for proper post-translational modification of proteins including glycosylation and the assembly of multiple-subunit proteins 7. This ability puts plant-based systems ahead of those based on prokaryotic systems, such as bacteria, since a wider number of pharmaceutical recombinant proteins, including monoclonal antibodies (mAbs), have a more complicated structure and require extensive posttranslational modifications or assembly 8.
There are two major approaches to expressing recombinant proteins in plants. The first is the development of a stably transgenic line, where DNA coding for the target protein is cloned into an expression cassette and introduced to either the nuclear or chloroplast genomes. In doing so, the foreign DNA becomes heritable through succeeding generations and allows for tremendously improved scalability, far beyond that of other expression systems 1. Introduction of exogenous DNA to the nuclear genome is usually achieved by Agrobacterium tumefaciens infection of plant tissue or, less often, by microprojectile bombardment of the tissue 9. Plant hormones are then used to induce differentiation and growth of transgenic plant tissue such as roots and leaves. Transformation of the chloroplast genome cannot be achieved with A. tumefaciens, but relies entirely on gold or tungsten particles coated with DNA fired ballistically into plant cells. The second method of expressing recombinant protein in plants is through transient expression 10. In this scenario, virus-derived vectors harboring the gene of interest are delivered via A. tumefaciens to fully developed plants through a process called agroinfiltration. Instead of integrating into the plant genome, the delivered gene construct will then begin to direct the transient production of the desired protein, which can be harvested and isolated after a short incubation period. Transient gene expression offers the advantage of greater overall protein accumulation as well as an improved time of protein production, as plants will be ready to harvest approximately 1-2 weeks after agroinfiltration 11. This is significantly faster than the processes of generation, selection, and confirmation of stable transgenic plant lines, which can take several months to a year. This however, is also the limitation of the transient expression system, as it will not yield genetically stable plant lines that can be used to generate a seed bank for large scale commercial production. Despite this, approaches have been developed to improve large scale transient expression. Here we demonstrate one method of generation of transient protein-expressing Nicotiana benthamiana plants using deconstructed viral vectors delivered by A. tumefaciens.
Two major methods are being developed for the delivery of A. tumefaciens into plant tissue: bench scale infiltration via syringe and large scale infiltration via vacuum chamber. Both protocols are described here using N. benthamiana, which is closely related to the common tobacco plant, as the host plant for transient expression of two fluorescent proteins: the green fluorescent protein (GFP) from jellyfish Aequorea victoria and the red fluorescent protein from Discosoma coral (DsRed) 12,13. N. benthamiana is the most common host plant for recombinant protein because it is amenable to genetic transformation, can yield high amounts of biomass rapidly, and is a prolific seed producer for scale-up production 14. Another advantage of using N. benthamiana as hosts for protein expression is the availability of a variety of expression vectors 2,5. In this study, two deconstructed viral vectors, one based on a tobacco mosaic virus (TMV) RNA replicon system (MagnICON vectors) and the other derived from the bean yellow dwarf virus (BeYDV) DNA replicon system (geminiviral vectors) 4,11,15-18 , are used to carry the GFP and DsRed gene and deliver them into N. benthamiana cells via A. tumefaciens. Three DNA constructs will be used for GFP or DsRed expression with MagnICON vectors. They include the 5' module (pICH15879) containing the promoter and other genetic elements for driving the expression of the target gene, the 3' module containing the gene of interest (pICH-GFP or pICH-DsRed), and the integrase module (pICH14011) coding for an enzyme that integrates the 5' and 3' modules together upon expression 8,15. Three DNA constructs are also needed for expression with geminiviral vectors. In addition to vectors containing the replicon of the target gene ( pBYGFP or pBYDsRed), a vector coding for the replication protein (pREP110) is required for the amplification of the target replicon 11,14,16. Furthermore, the inclusion of a vector encoding the silencing suppressor p19 from tomato bushy stunt virus is desired for high level target gene expression 11,16.
There are generally three major steps for the introduction of genes of recombinant proteins into plant cells by agroinfiltration including plant growth, A. tumefaciens culture preparation, and infiltration. As every step is critical for the ultimate success of this procedure, therefore, a detailed description for each is provided for both syringe infiltration and vacuum infiltration below.